Cargando…
Combination of immunotherapy with chemotherapy in first line treatment of metastatic gastric cancer? Too much, too little or just right?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812240/ https://www.ncbi.nlm.nih.gov/pubmed/33490204 http://dx.doi.org/10.21037/atm-20-4699 |
| _version_ | 1783637627842330624 |
|---|---|
| author | Ng, Matthew C. H. Choo, Su Pin |
| author_facet | Ng, Matthew C. H. Choo, Su Pin |
| author_sort | Ng, Matthew C. H. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7812240 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78122402021-01-22 Combination of immunotherapy with chemotherapy in first line treatment of metastatic gastric cancer? Too much, too little or just right? Ng, Matthew C. H. Choo, Su Pin Ann Transl Med Editorial Commentary AME Publishing Company 2020-12 /pmc/articles/PMC7812240/ /pubmed/33490204 http://dx.doi.org/10.21037/atm-20-4699 Text en 2020 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Commentary Ng, Matthew C. H. Choo, Su Pin Combination of immunotherapy with chemotherapy in first line treatment of metastatic gastric cancer? Too much, too little or just right? |
| title | Combination of immunotherapy with chemotherapy in first line treatment of metastatic gastric cancer? Too much, too little or just right? |
| title_full | Combination of immunotherapy with chemotherapy in first line treatment of metastatic gastric cancer? Too much, too little or just right? |
| title_fullStr | Combination of immunotherapy with chemotherapy in first line treatment of metastatic gastric cancer? Too much, too little or just right? |
| title_full_unstemmed | Combination of immunotherapy with chemotherapy in first line treatment of metastatic gastric cancer? Too much, too little or just right? |
| title_short | Combination of immunotherapy with chemotherapy in first line treatment of metastatic gastric cancer? Too much, too little or just right? |
| title_sort | combination of immunotherapy with chemotherapy in first line treatment of metastatic gastric cancer? too much, too little or just right? |
| topic | Editorial Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812240/ https://www.ncbi.nlm.nih.gov/pubmed/33490204 http://dx.doi.org/10.21037/atm-20-4699 |
| work_keys_str_mv | AT ngmatthewch combinationofimmunotherapywithchemotherapyinfirstlinetreatmentofmetastaticgastriccancertoomuchtoolittleorjustright AT choosupin combinationofimmunotherapywithchemotherapyinfirstlinetreatmentofmetastaticgastriccancertoomuchtoolittleorjustright |